A Randomized, Double-Blinded, Controlled, Parallel Group, Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures

Study Title
A Randomized, Double-Blinded, Controlled, Parallel Group, Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures
Sponsor Name
Cerus Corporation
NCT Number
NCT03459287
IDE Number
BB13803
CMS Approval Date
2018-10-05
Category
A

https://clinicaltrials.gov/ct2/show/NCT03459287